I agree that this site is using cookies. You can find further informations here.
X
Kuramochi, Hidekazu
52  results:
Search for persons X
?
1

Current status of the cost burden of first-line systemic tr..:

Imaoka, Hiroshi ; Sasaki, Keita ; Machida, Ryunosuke...
Japanese Journal of Clinical Oncology.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

A Case of Pathologically Complete Response After Nivolumab ..:

Izumo, Wataru ; Hosoda, Kei ; Kuramochi, Hidekazu...
Clinical and Experimental Gastroenterology.  16 (2023)  - p. 107-115 , 2023
Link: https://doi.org/10.2147/..
 
?
3

Effect of systemic inflammatory response on induction chemo..:

Mizuno, Nobumasa ; Ioka, Tatsuya ; Ogawa, Gakuto...
Japanese Journal of Clinical Oncology.  53 (2023)  8 - p. 704-713 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Characteristic cerebrospinal fluid findings in immune check..:

Wako, Sho ; Ikeguchi, Ryotaro ; Toda, Kunio...
Journal of Neuroimmunology.  374 (2023)  - p. 578010 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Biweekly TAS-102 and bevacizumab as third-line chemotherapy..:

Matsuoka, Hiroshi ; Yamada, Takeshi ; Ohta, Ryo...
International Journal of Clinical Oncology.  27 (2022)  12 - p. 1859-1866 , 2022
Link: https://doi.org/10.1007/..
 
?
6

Efficacy and safety of regorafenib dose-escalation therapy ..:

Ishiyama, Shun ; Yamada, Takeshi ; Nakamura, Masato...
International Journal of Clinical Oncology.  27 (2022)  8 - p. 1300-1308 , 2022
Link: https://doi.org/10.1007/..
 
?
7

A Trial Protocol of Precision Medicine for Patients with RA..:

Matsuda, Akihisa ; Yamada, Takeshi ; Takahashi, Takao...
Journal of the Anus, Rectum and Colon.  6 (2022)  1 - p. 52-57 , 2022
Link: https://doi.org/10.23922..
 
?
8

Impact of chronological age on efficacy and safety of fluor..:

Moriwaki, Toshikazu ; Nishina, Tomohiro ; Sakai, Yoshinori...
Japanese Journal of Clinical Oncology.  52 (2022)  7 - p. 725-734 , 2022
Link: https://doi.org/10.1093/..
 
?
9

Phase II study of neoadjuvant chemotherapy with S-1 plus ox..:

Serizawa, Akiko ; Kuramochi, Hidekazu ; Taniguchi, Kiyoaki...
Medical Oncology.  38 (2021)  9 - p. , 2021
Link: https://doi.org/10.1007/..
 
?
10

Randomised phase II study of panitumumab plus irinotecan ve..:

Sakai, Daisuke ; Taniguchi, Hiroya ; Sugimoto, Naotoshi...
European Journal of Cancer.  135 (2020)  - p. 11-21 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Combination of TAS-102 and bevacizumab as third-line treatm..:

Yoshida, Yoichiro ; Yamada, Takeshi ; Kamiyama, Hirohiko...
International Journal of Clinical Oncology.  26 (2020)  1 - p. 111-117 , 2020
Link: https://doi.org/10.1007/..
 
?
12

Influence of initial dose intensity on efficacy of FOLFIRIN..:

Kobayashi, Satoshi ; Ueno, Makoto ; Omae, Katsuhiro...
Oncotarget.  10 (2019)  19 - p. 1775-1784 , 2019
Link: https://doi.org/10.18632..
 
?
13

Dramatic response of FOLFIRINOX regimen in a collision panc..:

Shimmura, Hideki ; Kuramochi, Hidekazu ; Jibiki, Norie...
Japanese Journal of Clinical Oncology.  49 (2019)  11 - p. 1049-1054 , 2019
Link: https://doi.org/10.1093/..
 
?
14

The relationship between peripheral neuropathy and efficacy..:

Tanioka, Hiroaki ; Nagasaka, Takeshi ; Uno, Futoshi...
BMC Cancer.  19 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
15

Phase II study of bevacizumab and irinotecan as second-line..:

Kuramochi, Hidekazu ; Ando, Masayuki ; Itabashi, Michio...
Cancer Chemotherapy and Pharmacology.  79 (2017)  3 - p. 579-585 , 2017
Link: https://doi.org/10.1007/..
 
1-15